What is the optimal titration strategy for a male patient on sliding‑scale insulin with insulin lispro (Humalog) and an HbA1c of 9.5%?

Transition from Sliding Scale to Basal-Bolus Insulin Regimen

You should immediately discontinue the sliding scale insulin-only regimen and transition this patient to a structured basal-bolus insulin program, as sliding scale insulin alone is inadequate and explicitly not recommended for achieving glycemic control in diabetes management. 1

Why Sliding Scale Insulin Must Be Stopped

Multiple guidelines universally condemn sliding scale insulin as a sole therapy:

• Sliding scale insulin is explicitly listed as an approach to avoid in the 2025 American Diabetes Association Standards of Care 1
• The consensus across all major diabetes societies (ADA, Endocrine Society, Diabetes Canada, Australian Diabetes Society, International Diabetes Foundation) is that sliding scale insulin should not be used as the primary treatment modality 1
• With an HbA1c of 9.5%, this patient has significant hyperglycemia that requires scheduled insulin dosing, not reactive correction-only dosing 1

Recommended Transition Strategy

Step 1: Initiate Basal Insulin Immediately

Start basal insulin at 10 units per day OR 0.1-0.2 units/kg per day (choose a long-acting basal analog like glargine or detemir for once-daily dosing) 1

• Set a fasting plasma glucose goal of 80-130 mg/dL 1
• Titrate basal insulin by increasing 2 units every 3 days until reaching the fasting glucose goal without hypoglycemia 1
• If hypoglycemia occurs without clear cause, reduce the dose by 10-20% 1

Step 2: Continue Humalog as Prandial Insulin (Not Sliding Scale)

Convert the existing Humalog to scheduled prandial dosing rather than reactive sliding scale:

• Start with 4 units of Humalog before the largest meal or the meal with greatest postprandial glucose excursion 1
• Alternatively, start with 10% of the basal insulin dose as the prandial dose 1
• Increase prandial insulin by 1-2 units or 10-15% of the dose based on pre-meal and 2-hour postprandial glucose readings 1
• Humalog should be administered immediately before meals (0-15 minutes), not on a sliding scale schedule 2

Step 3: Systematic Titration Protocol

Reassess and modify the regimen every 3-6 months to avoid therapeutic inertia 1

The most effective titration approach based on recent evidence is:

• Self-titration at least twice weekly with healthcare provider support achieves superior HbA1c reduction compared to monthly provider-directed titration (mean difference of -1.19% compared to conventional low-frequency titration) 3
• This approach does not increase severe hypoglycemia risk 3

Step 4: Evaluate for Overbasalization

Monitor for clinical signals indicating the need for additional prandial insulin rather than continued basal escalation 1:

• Elevated bedtime-to-morning glucose differential
• Elevated postprandial-to-preprandial glucose differential
• Hypoglycemia (aware or unaware)
• High glucose variability
• Basal insulin dose approaching 0.5-1.0 units/kg/day without adequate fasting glucose control 4

Step 5: Consider Adjunctive Therapy

If HbA1c remains above goal after optimizing basal-bolus insulin, add a GLP-1 receptor agonist (if not already prescribed and if appropriate for the patient) 1

• GLP-1 RAs can be combined with insulin and may use fixed-ratio products if available 1
• This is particularly important given the HbA1c of 9.5% suggests significant insulin resistance 5

Critical Safety Considerations

Prescribe glucagon for emergent hypoglycemia when initiating or intensifying insulin therapy 1

Common pitfall to avoid: Do not continue escalating basal insulin indefinitely without achieving fasting glucose goals—this represents overbasalization and requires re-evaluation of the entire regimen, not just dose increases 1, 4

Timing consideration for Humalog: In hyperglycemic patients (which this patient clearly is with HbA1c 9.5%), administering Humalog 15 minutes before meals may improve postprandial glucose excursion compared to at-meal injection 6